Clinical variable | Males | Females | Total | P-value* |
---|---|---|---|---|
Demographic | ||||
Sex | 6245 (54%) | 5319 (46%) | 11,564 (100%) | < 0.001 |
Age | 50.61 ± 17.68 | 47.37 ± 17.19 | 49.12 ± 17.53 | – |
Age-group | ||||
< 19 | 134 (1%) | 140 (1%) | 274 (2%) | – |
20—29 | 657 (6%) | 696 (6%) | 1353 (12%) | – |
30—39 | 1091 (9%) | 1127 (10%) | 2218 (19%) | – |
40—49 | 1149 (10%) | 1072 (9%) | 2221 (19%) | – |
50—59 | 1150 (10%) | 951 (8%) | 2101 (18%) | – |
60—69 | 1034 (9%) | 700 (6%) | 1734 (15%) | – |
> 70 | 1030 (9%) | 633 (6%) | 1663 (14%) | – |
Comorbidities | ||||
Hypertension | 1567 (14%) | 1225 (11%) | 2792 (24%) | < 0.001 |
Diabetes | 1266 (11%) | 997 (9%) | 2263 (20%) | < 0.001 |
Obesity | 1005 (9%) | 954 (8%) | 1959 (17%) | 0.487 |
Smoking | 547 (5%) | 190 (2%) | 737 (6%) | 0.004 |
CKD | 219 (2%) | 126 (1%) | 345 (3%) | < 0.001 |
Cardiovascular diseases | 150 (1%) | 106 (1%) | 256 (2%) | < 0.001 |
COPD | 101 (1%) | 129 (1%) | 230 (2%) | < 0.001 |
Asthma | 88 (1%) | 132 (1%) | 220 (2%) | 0.042 |
Immunosuppression | 36 (0%) | 38 (0%) | 74 (1%) | 0.016 |
Symptoms | ||||
Cough | 5469 (47%) | 4553 (39%) | 10,022 (87%) | < 0.001 |
Headache | 5211 (45%) | 4609 (40%) | 9820 (85%) | < 0.001 |
Fever | 5429 (47%) | 4353 (38%) | 9782 (85%) | < 0.001 |
Myalgia | 4677 (40%) | 3979 (34%) | 8656 (75%) | 0.007 |
Arthralgia | 4444 (38%) | 3719 (32%) | 8163 (71%) | < 0.001 |
Odynophagia | 3771 (33%) | 3281 (28%) | 7052 (61%) | 0.019 |
General discomfort | 3707 (32%) | 2877 (25%) | 6584 (57%) | < 0.001 |
Chills | 3297 (29%) | 2760 (24%) | 6057 (52%) | 0.310 |
Dyspnea | 3113 (27%) | 2025 (18%) | 5138 (44%) | < 0.001 |
Sudden onset of symptoms | 2191 (19%) | 1802 (16%) | 3993 (35%) | 0.019 |
Chest pain | 2079 (18%) | 1732 (15%) | 3811 (33%) | < 0.001 |
Rhinorrhea | 1796 (16%) | 1760 (15%) | 3556 (31%) | < 0.001 |
Diarrhea | 1301 (11%) | 1155 (10%) | 2456 (21%) | < 0.001 |
Anosmia | 933 (8%) | 995 (9%) | 1928 (17%) | < 0.001 |
Irritability | 940 (8%) | 816 (7%) | 1756 (15%) | 0.060 |
Dysgeusia | 807 (7%) | 915 (8%) | 1722 (15%) | < 0.001 |
Polypnea | 1065 (9%) | 650 (6%) | 1715 (15%) | < 0.001 |
Abdominal pain | 741 (6%) | 756 (7%) | 1497 (13%) | 0.551 |
Conjunctivitis | 638 (6%) | 580 (5%) | 1218 (11%) | < 0.001 |
Vomiting | 424 (4%) | 459 (4%) | 883 (8%) | 0.240 |
Cyanosis | 239 (2%) | 137 (1%) | 376 (3%) | < 0.001 |
Medication | ||||
Use of antipyretics | 3268 (28%) | 2793 (24%) | 6061 (52%) | 0.014 |
Days elapsed from the onset of symptoms to the start of medical care | 3.51 ± 2.42 | 3.42 ± 2.37 | 3.47 ± 2.40 | - |
Lethality (death/no death) | 1084 (9%) | 538 (5%) | 1622 (14%) | - |